gastrografin
meglumine diatrizoate; sodium diatrizoate -
cystografin- diatrizoate meglumine injection, solution
bracco diagnostics inc - diatrizoate meglumine (unii: 3x9mr4n98u) (diatrizoic acid - unii:5uvc90j1lk) - this preparation is contraindicated in patients with a hypersensitivity to salts of diatrizoic acid.
gastrografin solution
bracco imaging canada - diatrizoate meglumine; diatrizoate sodium - solution - 66%; 10% - diatrizoate meglumine 66%; diatrizoate sodium 10% - roentgenography
hypaque - cysto- diatrizoate meglumine injection, solution
amersham health inc. - diatrizoate meglumine (unii: 3x9mr4n98u) (diatrizoic acid - unii:5uvc90j1lk) - injection, solution - 30 g in 100 ml - hypaque-cysto is indicated for retrograde cystourethrography in adult and pediatric patients. hypaque-cysto has no absolute contraindication in its recommended use.
urografin
bayer australia ltd - sodium diatrizoate; meglumine diatrizoate -
gastrografin
bayer plc - meglumine amidotrizoate; sodium amidotrizoate - gastroenteral solution - meglumine amidotrizoate 660 mg/ml; sodium amidotrizoate 100 mg/ml - contrast media
cystografin dilute- diatrizoate meglumine injection, solution
bracco diagnostics inc - diatrizoate meglumine (unii: 3x9mr4n98u) (diatrizoic acid - unii:5uvc90j1lk) - this preparation is contraindicated in patients with a hypersensitivity to salts of diatrizoic acid.
gastrografin solution
bayer (south east asia) pte ltd - meglumine amidotrizoate; sodium amidotrizoate - solution - 0.66 g/ml - meglumine amidotrizoate 0.66 g/ml; sodium amidotrizoate 0.1 g/ml
gastrografin
bayer hellas s.a 6-8 agisilaou street 151 23 marousi attiki, , greece - meglumine amidotrizoate, sodium amidotrizoate - gastroenteral solution - sodium amidotrizoate 10 g/100ml meglumine amidotrizoate 66 g/100ml - contrast media
hypaque oral powder
ge healthcare canada inc - diatrizoate sodium - powder - 997.4mg - diatrizoate sodium 997.4mg - roentgenography